Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.
Press releases published on June 24, 2025
Houston Optometrist Highlights Overlooked Summer Eye Dangers
EIN Presswire
·
June 24, 2025
Houston optometrist warns of hidden summer eye dangers like dry eyes, UV damage, and screen strain—and shares simple tips for prevention. HOUSTON, TX, UNITED STATES, June 24, 2025 /EINPresswire.com/ -- While many Houstonians welcome summer with open …
Japanese Researchers Develop Medication for Growing New Teeth by 2030
EIN Presswire
·
June 24, 2025
HOUSTON , TX, UNITED STATES, June 24, 2025 /EINPresswire.com/ -- A team of researchers in Japan is testing a new medication to grow teeth. If the current studies continue to show positive results, the treatment, which blocks a protein that suppresses …
Valencia Lifestyle Signs 11,763 SF New Lease at 4100 Alpha Rd
EIN Presswire
·
June 24, 2025
Boxer Property is pleased to announce that Valencia Lifestyle, led by renowned physician Dr. Daniel Valencia-Lopez, has signed a new lease. DALLAS, TX, UNITED STATES, June 24, 2025 /EINPresswire.com/ -- Boxer Property is pleased to announce that …
RELEASING ON JULY 1, 2025: Walking Each Other Home: A Caregiver’s Journey of Grace
EIN Presswire
·
June 24, 2025
"Walking Each Other Home" is a powerful faith-driven guide for caregivers and families facing Alzheimer’s and elder care challenges. DALLAS, TX, UNITED STATES, June 24, 2025 /EINPresswire.com/ -- Ann-Marie Murrell, acclaimed author, journalist, actress …
Aja Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements
GlobeNewswire
·
June 24, 2025
Not for dissemination in the United States of America VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that it is getting closer to filing its annual audited financial …
Pediatric Dentist Dr. Molly Gunsaulis of Dentistry for Children Shares Expert Insight on Understanding Tongue-Ties and Their Impact in HelloNation
GlobeNewswire
·
June 24, 2025
SPOKANE VALLEY, Wash., June 24, 2025 (GLOBE NEWSWIRE) -- What are the lasting effects of tongue-ties in children, and when should parents seek treatment? Dr. Molly Gunsaulis of Dentistry for Children in Spokane Valley, Washington addresses this in …
SciSparc Announces 1-for-21 Reverse Share Split
GlobeNewswire
·
June 24, 2025
Tel Aviv, Israel, June 24, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (“SciSparc” or the “Company”) (Nasdaq: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central …
Cue Biopharma Receives FDA Feedback on Pre-IND Briefing Document Reinforcing Company’s Intention to Advance IND Submission for CUE-401 to Address Unmet Need in the Treatment of Autoimmune Disease
GlobeNewswire
·
June 24, 2025
BOSTON, June 24, 2025 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …
TerrAscend Announces Results of Annual General Meeting
GlobeNewswire
·
June 24, 2025
TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND, OTCQX: TSNDF), a leading North American cannabis company, today announced the results of its annual meeting of shareholders held on June 24, 2025 (the …
Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market
GlobeNewswire
·
June 24, 2025
GAITHERSBURG, Md., June 24, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer …
Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary
GlobeNewswire
·
June 24, 2025
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 24, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or …
NeuroPace Announces Strategic CFO Transition
GlobeNewswire
·
June 24, 2025
Appoints Patrick F. Williams as Chief Financial Officer Williams Brings a Track Record of Leading Medical Device Public Companies as CFO Rebecca Kuhn Departing Company and Will Remain in Advisory Role MOUNTAIN VIEW, Calif., June 24, 2025 (GLOBE NEWSWIRE) …
InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke
GlobeNewswire
·
June 24, 2025
MIAMI, June 24, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (the “Company”) (Nasdaq: NSPR), developer of the CGuard Prime Carotid Stent System for the prevention of stroke, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket …
BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at the Advanced Therapeutics in Movement & Related Disorders® Congress
GlobeNewswire
·
June 24, 2025
CARSON CITY, Nev., June 24, 2025 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver …
Corbus Pharmaceuticals to Participate in the 3rd Annual Piper Obesity Symposium
GlobeNewswire
·
June 24, 2025
NORWOOD, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will participate in a fire side chat at the …
Syndax Announces FDA Priority Review of sNDA for Revuforj® (revumenib) in Relapsed or Refractory mNPM1 Acute Myeloid Leukemia
GlobeNewswire
·
June 24, 2025
– PDUFA action date set for October 25, 2025 – – sNDA being reviewed under FDA’s RTOR program – – Revumenib has the potential to become the first and only menin inhibitor approved in both R/R mNPM1 AML and R/R KMT2Ar acute leukemia – NEW YORK, June 24, …
Abvance Therapeutics Secures Strategic Seed Financing & Leadership Expansion at ADA Scientific Sessions
GlobeNewswire
·
June 24, 2025
CHICAGO, June 24, 2025 (GLOBE NEWSWIRE) -- Abvance Therapeutics, a biotechnology company developing next-generation glucagon analogs and therapies to prevent hypoglycemia and improve glucose management, today announced the closing of its initial seed …
Virginia Beach Boy Shot in Head Finds Road to Recovery at Children's Hospital of The King's Daughters
GlobeNewswire
·
June 24, 2025
Norfolk, Virginia, June 24, 2025 (GLOBE NEWSWIRE) -- NORFOLK, Va. – Emily Rigsby and Steven Davis sat next to their son, Landyn, in the pediatric intensive care unit desperately watching for any sign that he would be OK. The 8-year-old had been playing …
Shiny Smile Veneers Named Top Snap-On Veneer Brand in the US by Independent Review Platforms
GlobeNewswire
·
June 24, 2025
Houston, TX, June 24, 2025 (GLOBE NEWSWIRE) -- Shiny Smile Veneers, a US-based provider of custom-made snap-on veneers, has once again been recognized as one of the top snap-on veneer brands in the country, this time by two leading dental product resources …
Carestream Demonstrates Commitment to Sustainability with Better Stands Silver Award at Hospitalar 2025
GlobeNewswire
·
June 24, 2025
SÃO PAULO, June 24, 2025 (GLOBE NEWSWIRE) -- Carestream Health was honored with the Better Stands Silver Award at Hospitalar 2025, recognizing the company’s efforts towards sustainability and reducing its environmental footprint by implementing a reusable …